Skip to main content
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
EN
FR
EN
PT
NL
NB
DE
IT
Home
Company Press Releases
Company press releases
Subscribe
Filters
Filters
Refresh
Reset
Icon After
Date
Toggle Visibility
All
Today
This week
This month
Custom date range
From
To
Topic
Toggle Visibility
Acquisition or disposal of the issuer’s own shares
Additional regulated information required to be disclosed under the laws of a Member State
Adjustment of interest rate
Alliances and agreements
Annual financial and audit Reports
Change in Capital
Changes in the rights attaching to the classes of shares or securities
Commercial operations
Commercial results
Corporate life
Dividend
Ex Date
General meeting / Board Meeting
Half yearly financial reports and audit reports/limited reviews
Home Member State
Income
Inside information
Joint venture
Journal / appointments
Legal
Major shareholding notifications
Mandatory notification of trade primary insiders
Meetings / events
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Non-regulatory press releases
Other financial transaction
Other subject
Payments to governments
Polls / Surveys
Products and services
Prospectus / admission document
Rating
Sales
Share history
Share introduction and issues
Takeover bids
Total number of voting rights and capital
Trends / Analyses
Provider
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Displaying 1 - 28 of 28 results
Released
Company
Title
Industry
Topic
27 Aug 2024
13:00 CEST
PHARNEXT
Ouverture d'une procédure de liquidation judiciaire
20103010 Biotechnology
Legal
01 Aug 2024
18:00 CEST
PHARNEXT
Ajustement de la valeur nominale
20103010 Biotechnology
Legal
18 Jul 2024
18:00 CEST
PHARNEXT
Point concernant l'accord de financement en obligations convertibles accordé par Global Tech Opportunities 13
20103010 Biotechnology
Legal
15 Jul 2024
18:00 CEST
PHARNEXT
Demande d'ouverture d'une procédure de liquidation judiciaire
20103010 Biotechnology
Legal
10 Jul 2024
08:00 CEST
PHARNEXT
Pharnext fait un point sur sa situation financière
20103010 Biotechnology
Legal
04 Jul 2024
20:00 CEST
PHARNEXT
Pharnext annonce la résiliation du contrat de financement accordé par Néovacs
20103010 Biotechnology
Legal
03 Jul 2024
08:00 CEST
PHARNEXT
Pharnext fait un point sur les conséquences de sa situation stratégique et financière
20103010 Biotechnology
Legal
01 Jul 2024
18:30 CEST
PHARNEXT
Information relative au nombre total de droits de vote et d'actions composant le capital social
20103010 Biotechnology
Change in Capital
28 Jun 2024
08:00 CEST
PHARNEXT
Pharnext fait un point d'étape sur les dernières avancées majeures d'un point de vue opérationnel et financier
20103010 Biotechnology
Legal
18 Jun 2024
18:30 CEST
PHARNEXT
Pharnext annonce la prorogation de la procédure de conciliation jusqu'au 15 juillet 2024
20103010 Biotechnology
Legal
05 Jun 2024
18:30 CEST
PHARNEXT
Information relative au nombre total de droits de vote et d'actions composant le capital social
20103010 Biotechnology
Change in Capital
29 May 2024
18:00 CEST
PHARNEXT
Ajustement de la valeur nominale
20103010 Biotechnology
Legal
07 May 2024
19:10 CEST
PHARNEXT
Ajustement de la valeur nominale
20103010 Biotechnology
Legal
06 May 2024
18:00 CEST
PHARNEXT
Pharnext convoque ses actionnaires en assemblée générale le 10 juin 2024
20103010 Biotechnology
General meeting / Board Meeting, Meetings / events
02 May 2024
18:30 CEST
PHARNEXT
Information relative au nombre total de droits de vote et d'actions composant le capital social
20103010 Biotechnology
Change in Capital
30 Apr 2024
23:45 CEST
PHARNEXT
Pharnext publie ses résultats 2023 et présente les avancées de la procédure de conciliation
20103010 Biotechnology
Sales, Income, Commercial results
25 Apr 2024
08:30 CEST
PHARNEXT
Pharnext a présenté les données de l'étude pivot de Phase III de PXT3003 dans la maladie de Charcot-Marie-Tooth de type 1A au congrès annuel de CMT-France
20103010 Biotechnology
Legal
02 Apr 2024
18:30 CEST
PHARNEXT
Information relative au nombre total de droits de vote et d'actions composant le capital social
20103010 Biotechnology
Change in Capital
20 Mar 2024
19:30 CET
PHARNEXT
Ajustement de la valeur nominale
20103010 Biotechnology
Legal
11 Mar 2024
16:30 CET
PHARNEXT
Pharnext fait un point complet sur sa situation opérationnelle, stratégique et financière
20103010 Biotechnology
Legal
11 Mar 2024
16:30 CET
PHARNEXT
Pharnext takes full stock of its operating, strategic and financial situation
20103010 Biotechnology
Legal
06 Mar 2024
08:30 CET
PHARNEXT
Pharnext annonce une suspension de cotation de ses titres dans l'attente d'un point complet sur sa situation opérationnelle, stratégique et financière
20103010 Biotechnology
Legal
01 Mar 2024
18:00 CET
PHARNEXT
Information relative au nombre total de droits de vote et d'actions composant le capital social et à la valeur nominale des actions
20103010 Biotechnology
Change in Capital
28 Feb 2024
08:30 CET
PHARNEXT
Pharnext progresse dans l'analyse des données de l'étude pivot de Phase III de PXT3003 dans la maladie de Charcot-Marie-Tooth de type 1A
20103010 Biotechnology
Legal
28 Feb 2024
08:30 CET
PHARNEXT
Pharnext progresses in analyzing data from pivotal Phase III study of PXT3003 in Charcot-Marie-Tooth disease type 1A
20103010 Biotechnology
Legal
20 Feb 2024
18:00 CET
PHARNEXT
Ajustement de la valeur nominale
20103010 Biotechnology
Legal
20 Feb 2024
18:00 CET
PHARNEXT
Levée de fonds de 250 mille euros
20103010 Biotechnology
Legal
15 Feb 2024
20:30 CET
PHARNEXT
Point à la suite de l'assemblée générale des actionnaires convoquée le 15 février 2024
20103010 Biotechnology
Legal
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
your account
section or
create an account
.
Home
Markets
Amsterdam
Cash Products
Stocks
AEX index Stocks
AEX ESG Stocks
Indices
Funds
Bonds
ETFs
Structured products
Derivative products
Index options
Index futures
Stock options
Dividend derivatives
Stock futures
Quote Vendor Codes
Company regulated news
Latest
Archive
Brussels
Cash products
Stocks
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indices
Bonds
ETFs
Structured Products
Derivative products
Index futures
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisbon
Cash Products
Stocks
Euronext regulated
Euronext Access
PSI Stocks
Indices
Bonds
Derivative products
Index futures
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Cash Products
Stocks
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX stocks
OBX ESG Stocks
OSEBX stocks
OSEFX Stocks
Seafood Stocks
Shipping Stocks
Equity indices
Bonds
Oslo Børs
Nordic Alternative Bond Market
Bond indices
ETFs
Funds
Derivatives
Derivative products
Quote Vendor Codes
Company regulated news
Latest
Archive
Financial calendars
Primary insiders
Paris
Cash Products
Stocks
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indices
Bonds
ETFs
Structured products
Derivative products
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Equities
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Company regulated news
Latest
Archive
IPOs
All IPOs
Listing sponsors
Euronext Tech Leaders
Family business
Indices
Directory
ESG indices
Indices documents
Indices news
Index consultations
Contact Euronext indices
ETFs
Directory
ESG ETFs
Funds
Directory
ESG Funds
Oslo Mutual Funds
Fixed Income
ESG Bonds
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Structured Products
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Equity Derivatives
Index Futures
Index Options
Stock Options
Stock Futures
Dividend Derivatives
ETF Options
Contracts specifications
Tick Sizes
Wholesale Trading
Quote vendor codes
Commodities
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Trading calendars
Delivery
Wholesale Trading
Commitments of Traders (CoT) report
Contracts specifications
Quote vendor codes
DSP
Education
Academy
Stocks Education
Option education
Our Indices
Educational videos
News & Insights
Resources
Statistics & reports
Quality of execution
Trading hours & Holidays
Contract specifications
Quote vendor codes
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Market events
Suspended instruments
Stressed Market Conditions
Breach of Double Cap limits
Exceptional Market Conditions
Miscellaneous short messages
Market status
Members list
Issuers compliance
Where to find